HAE: Clinical Trials

1 trial for HAE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Enrolling by invitation 1

Follow HAE: new trials by email Literature Review of HAE trials Research Report on HAE

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies
berotralstat - Hereditary Angioedema, HAE
Phase 3Enrolling by invitationBioCryst Pharmaceuticals1392021-07-232025-12-23

Narrower conditions

Angioedemas, Hereditary (1)

Broader conditions

Angioedema (1)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hereditary Complement Deficiency Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Primary Immunodeficiency Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Urticaria (1)  ·  Vascular Diseases (1)

Interventions

berotralstat (1)

Sponsors

BioCryst Pharmaceuticals (1)

Countries

Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  North Macedonia (1)  ·  Poland (1)  ·  Slovakia (1)  ·  South Africa (1)  ·  South Korea (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Vesna Grivcheva-Panoska, MD, PhD (1)